272 related articles for article (PubMed ID: 20129653)
1. HPV vaccine and males: issues and challenges.
Zimet GD; Rosenthal SL
Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
[TBL] [Abstract][Full Text] [Related]
2. Improving adolescent health: focus on HPV vaccine acceptance.
Zimet GD
J Adolesc Health; 2005 Dec; 37(6 Suppl):S17-23. PubMed ID: 16310137
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
[TBL] [Abstract][Full Text] [Related]
4. Prevention strategies against human papillomavirus in males.
Garland SM
Gynecol Oncol; 2010 May; 117(2 Suppl):S20-5. PubMed ID: 20138347
[TBL] [Abstract][Full Text] [Related]
5. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of human papillomavirus vaccine for males: a review of the literature.
Liddon N; Hood J; Wynn BA; Markowitz LE
J Adolesc Health; 2010 Feb; 46(2):113-23. PubMed ID: 20113917
[TBL] [Abstract][Full Text] [Related]
7. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
8. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
Mahoney MC
J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus vaccine acceptability among young adult men.
Gerend MA; Barley J
Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
[TBL] [Abstract][Full Text] [Related]
10. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
Ault K; Reisinger K
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus vaccine and men: what are the obstacles and challenges?
Stupiansky NW; Alexander AB; Zimet GD
Curr Opin Infect Dis; 2012 Feb; 25(1):86-91. PubMed ID: 22143118
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
13. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
14. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey.
Dempsey AF; Butchart A; Singer D; Clark S; Davis M
Sex Transm Dis; 2011 Aug; 38(8):769-76. PubMed ID: 21336230
[TBL] [Abstract][Full Text] [Related]
16. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults.
Kester LM; Shedd-Steele RB; Dotson-Roberts CA; Smith J; Zimet GD
Gynecol Oncol; 2014 Mar; 132 Suppl 1():S9-12. PubMed ID: 24384459
[TBL] [Abstract][Full Text] [Related]
17. Age considerations when vaccinating against HPV.
Wright TC; Huh WK; Monk BJ; Smith JS; Ault K; Herzog TJ
Gynecol Oncol; 2008 May; 109(2 Suppl):S40-7. PubMed ID: 18482558
[TBL] [Abstract][Full Text] [Related]
18. Overcoming barriers to adherence to HPV vaccination recommendations.
Dempsey AF; Davis MM
Am J Manag Care; 2006 Dec; 12(17 Suppl):S484-91. PubMed ID: 17203992
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against human papillomavirus in childhood: the next rubella analogue?
Mammas IN; Spandidos DA
J BUON; 2012; 17(2):389-90. PubMed ID: 22740223
[TBL] [Abstract][Full Text] [Related]
20. The prophylactic role for the human papillomavirus quadrivalent vaccine in males.
Yancey AM; Pitlick JM; Forinash AB
Ann Pharmacother; 2010; 44(7-8):1314-8. PubMed ID: 20501891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
